Evidence map›Paper›PMID 28777093›Full record

ArticleActa crystallographica. Section F, Structural biology communications2017

Expression and crystallographic studies of the D1D2 domains of C4.4A, a homologous protein to the urokinase receptor.

Shanli Chen, Lin Lin, Cai Yuan, Henrik Gårdsvoll, Mette C Kriegbaum, Michael Ploug, Mingdong Huang

Abstract read
In one paragraph

Article in Acta crystallographica. Section F, Structural biology communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shanli ChenCollege of Chemistry, Fuzhou Univerisity, Fuzhou, Fujian 350108, People's Republic of China.
Lin LinDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA.
Cai YuanCollege of Bioscience and Biotechnology, Fuzhou Univerisity, Fuzhou, Fujian 350108, People's Republic of China.
Henrik GårdsvollThe Finsen Laboratory, Rigshospitalet, DK-2200 Copenhagen, Denmark.
Mette C KriegbaumThe Finsen Laboratory, Rigshospitalet, DK-2200 Copenhagen, Denmark.
Michael PlougThe Finsen Laboratory, Rigshospitalet, DK-2200 Copenhagen, Denmark.
Mingdong HuangCollege of Chemistry, Fuzhou Univerisity, Fuzhou, Fujian 350108, People's Republic of China.

Funding

National Natural Science Foundation of China 31370737National Natural Science Foundation of China 31570745National Natural Science Foundation of China 31670739
6 · The paper itself

Abstract

C4.4A is a glycosylphosphatidylinositol-anchored membrane protein comprised of two LU domains (Ly6/uPAR-like domains) and an extensively O-glycosylated C-terminal Ser/Thr/Pro-rich region. C4.4A is a novel biomarker for squamous epithelial differentiation. Its expression is dysregulated under various pathological conditions and it is a robust biomarker for poor prognosis in various malignant conditions such as pulmonary adenocarcinoma. To facilitate crystallization, the two LU domains were excised from intact C4.4A by limited proteolysis, purified and crystallized by the sitting-drop vapour-diffusion method. The crystals diffracted to 2.7 Å resolution and belonged to space group C222

Indexed as

Amino Acid SequenceSequence DeletionAnimalsBiomarkers, TumorCell Adhesion MoleculesCloning, MolecularCrystallizationCrystallography, X-RayDrosophila melanogasterGene ExpressionGenetic VectorsGPI-Linked ProteinsHumansProtein DomainsReceptors, Urokinase Plasminogen ActivatorRecombinant ProteinsBiomarkers, TumorCell Adhesion MoleculesGPI-Linked ProteinsLYPD3 protein, humanReceptors, Urokinase Plasminogen ActivatorRecombinant ProteinsC4.4AglycosylationLU domainsprognostic cancer biomarkers

Identifiers

PMID28777093
PMCPMC5544007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.